| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Vivek Dhawan CEO | SET Exchange | TH4984010009 ISIN |
| TH Country | - Employees | 27 Aug 2025 Last Dividend | - Last Split | - IPO Date |
Mega Lifesciences Public Company Limited, established in 1982 and based in Bangkok, Thailand, operates in the health and wellness sector. The company, through its subsidiaries, engages in the manufacturing and sale of a wide range of health-related products including health food supplements, prescription pharmaceutical products, over-the-counter (OTC) items, herbal products, vitamins, and fast-moving consumer goods, primarily focusing on markets in Southeast Asia and Sub-Saharan Africa. Mega Lifesciences operates under three main business segments: Brands, Distribution, and Original Equipment Manufacture (OEM). A notable subsidiary of Unistretch Limited, the company also extends its services to logistical support and marketing for third-party products and has ventured into software design and development services.
The company offers a comprehensive range of medicines and supplements targeting various health concerns. These include allergies, blood circulation and memory enhancement, bone and joint care, liver and digestive health, eye, heart, and skin care, pain relief, sleep aids, general well-being, herbal remedies, cough, and cold remedies, as well as an assortment of vitamins, probiotics, medical, and sports nutrition products. Special care categories also cater to kids', men's, and women's health needs, ensuring a holistic approach to family well-being.
Mega Lifesciences provides an extensive portfolio of prescription medicines across a wide range of therapeutic areas. These areas include, but are not limited to, anti-allergic, anti-infective, treatments for the central nervous system, cardiovascular system, dermatology, diabetes management, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedics, pain management, respiratory care, rheumatology, and urology. This wide range ensures the company's presence in critical areas of healthcare and medical treatment.
Aside from its own product offerings, the company provides vital logistical and marketing services for goods manufactured by third parties. These services are designed to support the efficient distribution and sale of a variety of healthcare products, facilitating access to essential medicines and supplements across its operating regions.
In a diversification of its portfolio, Mega Lifesciences has also ventured into the technology sector, engaging in software design, development, and other related services. This expansion reflects the company's commitment to innovation and its recognition of the growing importance of technology in enhancing health services delivery.